Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

MDxHealth SA (O6C.MU)

Munich - Munich Delayed Price. Currency in EUR
0.7040+0.0080 (+1.15%)
At close: 08:04AM CET
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    MDxHealth Provides Business Update

    NEWS RELEASE – INSIDE AND REGULATED INFORMATION29 NOVEMBER 2022, 4:00PM EDT / 22:00 CET MDxHealth Provides Business Update IRVINE, CA, and HERSTAL, BELGIUM – November 29, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today provided clinical and reimbursement product developments, updated guidance for 2022, and initial guidance for 2023. Select mdx reimbursement update Under the foundational LCD (Local Coverage Decision) process recently implemente

  • American City Business Journals

    Exact Sciences expects profitability in 2023, ahead of prior estimate

    Madison-based cancer screening and diagnostic test maker Exact Sciences Corp. said Thursday it expects to turn profitable in the third quarter of 2023, ahead of its previous target of 2024.

  • GlobeNewswire

    MDxHealth Reports Q3-2022 Results

    NEWS RELEASE - REGULATED INFORMATION27 OCTOBER 2022, 4:00PM EDT / 22:00 CET MDxHealth Reports Q3-2022 Results IRVINE, CA, and HERSTAL, BELGIUM – October 27, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced its financial results for the third quarter ended September 30, 2022. Michael K. McGarrity, CEO of mdxhealth, commented: “We are pleased to report continued strong operating results for the third quarter 2022. Our focus on operating

Advertisement
Advertisement